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Abstract—Parkinson’s disease (PD) is one of the major public
health problems in the world. It is a well-known fact that
around one million people suffer from Parkinson’s disease in
the United States whereas the number of people suffering from
Parkinson’s disease worldwide is around 5 millions. Thus, it is
important to predict Parkinson’s disease in early stages so that
early plan for the necessary treatment can be made. People are
mostly familiar with the motor symptoms of Parkinson’s disease,
however an increasing amount of research is being done to predict
the Parkinson’s disease from non-motor symptoms that precede
the motor ones. If early and reliable prediction is possible then
a patient can get a proper treatment at the right time. Non-
motor symptoms considered are Rapid Eye Movement (REM)
sleep Behaviour Disorder (RBD) and olfactory loss. Developing
machine learning models that can help us in predicting the
disease can play a vital role in early prediction. In this paper we
extend a work which used the non-motor features such as RBD
and olfactory loss. Along with this the extended work also uses
important biomarkers. In this paper we try to model this classifier
using different machine learning models that have not been
used before. We developed automated diagnostic models using
Multilayer Perceptron, BayesNet, Random Forest and Boosted
Logistic Regression. It has been observed that Boosted Logistic
Regression provides the best performance with an impressive
accuracy of 97.159 % and the area under the ROC curve was
98.9%. Thus, it is concluded that this models can be used for
early prediction of Parkinson’s disease.
Keywords—Improved Accuracy, Prediction of Parkinson’s Dis-
ease, Non Motor Features, Biomarkers, Machine Learning Tech-
niques, Boosted Logistic Regression, BayesNet, Multilayer Per-
ceptron,
I. INTRODUCTION
Parkinson’s disease (PD) is a chronic, degenerative neu-
rological disorder. The main cause of Parkinson’s disease is
actually unknown. However, it has been researched that the
combination of environmental and genetic factors play an
important role in causing PD [1]. For general understanding
the Parkinson’s disease is treated as disorder of the central
nervous system which is the result of loss of cells from various
parts of the brain. These cells also include substantia nigra
cells that produce dopamine. Dopamine plays a vital role in
the coordination of movement. It acts as a chemical messenger
for transmitting signals within the brain. Due to the loss of
these cells, patients suffer from movement disorder.
The symptoms of PD can be classified into two types i.e.
non-motor and motor symptoms. Many people are aware of
the motor symptoms as they can be visually perceived by
human beings. These symptoms are also called as cardinal
symptoms, these include resting tremor, slowness of movement
(bradykinesia), postural instability (balance problems) and
rigidity [2]. It is now established that there exists a time-
span in which the non-motor symptoms can be observed.
This symptoms are called as dopamine-non-responsive symp-
toms. These symptoms include cognitive impairment, sleep
difficulties, loss of sense of smell, constipation, speech and
swallowing problems, unexplained pains, drooling, constipa-
tion and low blood pressure when standing. It must be noted
that none of these non-motor symptoms are decisive, however
when these features are used along with other biomarkers
from Cerebrospinal Fluid measurement (CSF) and dopamine
transporter imaging, they may help us to predict the PD.
In this paper we extend works by Prashant et al [3]. This
work takes into consideration the non-motor symptoms and
the biomarkers such as cerebrospinal fluid measurements and
dopamine transporter imaging. In this paper we follow a simi-
lar approach, however we try to use different machine learning
algorithms that can help in improving the performance of
model and also play a vital role in making in early prediction
of PD which in turn will help us to initiate neuroprotective
therapies at the right time.
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The rest of the paper is organized as follows. Section 2 con-
tains the related work. Section 3 contains the flowchart of the
analysis carried out and describes about the PPMI database,
explanation of different features extracted, statistical analysis
of this features, classification and prediction/prognostic model
design. Section 4 provides the results and discussion from the
experiments carried out. And finally conclusion of the work
is provided in Section 5.
II. RELATED RESEARCH WORK
Different researchers have used different features and data
to predict Parkinson’s disease. Indira et al. [4] have used
biomedical voice of human as the main feature. The authors
have developed a model to automatically predict whether a
person is suffering from PD by analysing the voice of the
patients. They have used fuzzy c-means (FCM) clustering and
pattern recognition methods on the dataset and have attained
an accuracy of 68.04%, 75.34% sensitivity and 45.83% speci-
ficity. Amit et al. [5] have presented a unique approach of
classifying PD patients on the basis of their postural instability
and have used L2 norm metric in conjunction with support
vector machine. In [6], the authors have applied University of
Pennsylvania 40-item smell identification test (UPSIT-40) and
16-item identification test from Sniffins Sticks. This study was
conducted on Brazilian population. The authors have applied
logistic regression considering each of the above features sep-
arately. They observed that the Sniffin Sticks gave a specificity
of 89.0 % and a sensitivity of 81.1 %. Similarly they found out
that the UPSIT-40 specificity was 83.5% and sensitivity 82.1%.
Prashant et al. [7] have used olfactory loss feature loss from
40-item UPSIT and sleep behaviour disorder from Rapid eye
movement sleep Behaviour Disorder Screening Questionnaire
(RBDSQ). Support Vector machine and classification tree
methods have been employed to train their methods. They
have reported an accuracy of 85.48% accuracy and 90.55%
sensitivity. This work has been extended by the same authors
in [3]. In this paper they added new features in the form
of CSF measurements and SPECT imaging markers. They
reported an accuracy of 96.40% and 97.03% sensitivity. This
paper has motived us to further the study. In the present
paper an attempt has been made to improve the accuracy
by using advanced machine learning models. Some recent
machine learning algorithms have been chosen for prediction
and have made a comparative performance analysis of these
models based on accuracy, area under the ROC curve and other
measures.
III. MATERIALS AND METHODS
A flowchart of the proposed analysis is shown in Fig 1.
The data was first collected and the required non-motor and
biomarker features are then extracted. Then different machine
learning algorithms are employed for the classification task.
Finally, a comparative analysis is made based on the accuracy
provided by different machine learning models.
A. Database
In this study the data from Parkinson’s Progression Markers
Initiative (PPMI) database [8] was obtained. PPMI is an obser-
vational, multicentre study that collects clinical and imaging
data and biologic samples from various cohorts that can be
used by researchers to establish markers of disease progression
in PD. PPMI has established a comprehensive, standardized,
longitudinal PD data and biological sample repository that can
play a vital role in the development of tools which assist in
prediction of PD. To obtain the recent information, the official
website of PPMI. ( www.ppmi-info.org ) can be visited. This
dataset is similar to the one used in [3]. We downloaded the
database on 8th August 2016. On this date the data of 184
normal patients and 402 early PD subjects were collected. It
is noted that PPMI has observations from each of the patients
at different time intervals. Thus the data of each patient at
different periods like screening or baseline, first visit, second
visit and so on are available. In the present investigation the
data at baseline observation are considered.
In [3] , the authors have used features from University
of Pennsylvania Smell Identification Test, RBD screening
questionnaire, CSF Markers of Aβ1-42,α- syn, P-tau181, T-
tau, T-tau/Aβ1-42, P-tau181/Aβ1-42 and P-tau181/T tau, and
SPECT measurements of striatal binding ratio (SBR) data.
In this study these features have been used because we felt
that they are a good combination of non-motor features and
biomarkers. The details of these features are given in section
III B.
B. Feature Description
1) University of Pennsylvania Smell Identification Test (UP-
SIT): Olfactory dysfunction is an important marker of Parkin-
son’s disease [9]. It acts as sensitive and early marker for
Parkinson’s disease. It is a fact that most of the people who
suffer from PD have olfactory loss however it doesn‘t mean
that all the people with olfactory loss are suffering from PD
[10]. Olfactory dysfunction are in various forms for instance it
may be impairment in odour detection or odour differentiation.
A study by Posen et al [11] showed that about 10% of the
subjects who were suffering from odour dysfunction were at
the risk of PD.
For quantifying this odour loss the data of University of
Pennsylvania Smell Identification Test is used. This test is
commercially available and is also one of the most reliable
tests [12]. The procedure of the test is as follows. A subject is
provided with 4 different 10 page booklets. Each of this pages
has a different odour. A subject has to scratch the page and
smell it. For each of this pages, there exists a question with
four options. Depending on the odour the subject selects one
of the options. This procedure is repeated for all the pages in
all the booklets. Once the test is completed the UPSIT score
is calculated. The maximum score can be 40 when the subject
identifies each of the odours correctly. One main advantage of
this is that the test takes only a few minutes. For the present
analysis the UPSIT score at baseline check-up from PPMI [8]
has been taken.
2) REM sleep Behaviour Disorder Screening Questionnaire
(RBDSQ): RBD is another non-motor symptom that plays an
important role in early prediction of Parkinson’s disease. Peo-
ple suffering from RBD have disturbances in sleep. These dis-
turbances include vivid, aggressive or action packed dreams.
Similar to olfactory loss, studies have shown that disorder
in sleep behaviour increases the risk of being affected with
Parkinson’s disease. For quantifying this non-motor symptom,
the REM Sleep Behaviour Disorder Screening Questionnaire is
used. The RBDSQ is a 10-item patient self-rating instrument
[13]. The test contains ten short questions with answers as
yes or no. A yes is equivalent to 1 and a no is equivalent
to 0. The ten questions are divided such that each of the
group of the questions provides the observations about a
particular behaviour. Some of the examples of the questions
from [13] are “I sometimes have vivid dreams”, “The dream
contents mostly matches my nocturnal behaviour”, “My sleep
is frequently disturbed”, etc. As some of the subjects may have
a bed partner, they can also be used in this test.
Each of the answers are provided as either one or zero. In
the present study the feature for sleep disorder is obtained by
summing up all the answers. This sum can be a maximum
of 12 if we take the first nine questions. It is observed here
that a higher score in this case means a higher risk of PD in
contrast to that of UPSIT score. This RBDSQ score is taken
from PPMI [8].
3) Cerebrospinal Fluid Biomarkers: Biomarkers play a
pivotal role in this analysis. Without the aid of biomarkers
the prediction of PD is less accurate. The biomarkers are the
significant factors in increasing the accuracy of the model.
Biomarkers need to be sensitive, reproducible and must be
closely associated with the disease. Cerebrospinal fluid is a
clear, colourless body fluid found in the brain. It has more
physical contact with the brain as compared to any other fluid
[14]. Due to the close proximity with the brain, any protein
or peptide which is related to the brain specific functionalities
or disease are diffused into CSF. Hence, the CSF can act as
an important biomarker for brain related diseases which in
the present case is Parkinson’s disease.
The CSF samples are collected from PPMI. In PPMI, for
each of subjects the CSF samples are obtained and certain
measurements are made. These measurements include Aβ1-
42(amyloid beta (1-42), T-tau (total tau) and P-tau181 (tau
phosphorylated at threonine) [15]. According to PPMI Re-
search Laboratory these three are the important biomarkers
that can be extracted from the CSF fluid. Along with this
the concentration of α-Syn was also collected from PPMI
database. Kang et al have mentioned that ratios like T-
tau/Aβ1-42, P-tau181/Aβ1-42 and P-tau181/T-tau also play
a significant role in early detection of Parkinson’s disease
[16]. In the present investigation the measurements of Aβ1-
42, T-tau and P-tau181 and also the ratios T- tau/Aβ1-42, P-
tau181/Aβ1-42 and P-tau181/T-tau are taken.
4) Neuroimaging markers: Single-photon emission com-
puted tomography (SPECT) is a neuroimaging technique that
uses gamma rays [17]. The SPECT is a common routine for
helping a doctor to decide whether a subject is suffering from
neurodegenerative diseases. According to [18], the SPECT
imaging can detect the dopaminergic transporter loss during
the early stages of PD. When a subject has an abnormal scan-
ning then the person has more probability of being affected
with Parkinson’s disease or other neuro degenerative disease.
However, a normal scan denotes that the subject is suffering
from other type of diseases [18].
DatScan SPECT imaging obtained from PPMI imaging centres
are used in this study. At PPMI the striatal binding ratios
were calculated. The DatScan SPECT images are collected
according to the PPMI imaging protocol. This raw images are
then reconstructed so as to ensure consistency among different
imaging centres. After this attenuation correction is performed
on these images. After this the Gaussian filter is applied and
it is followed by normalization. Finally the required part is
extracted from the images and then the striatal binding ratio for
left and right caudate, the left and right putamen are calculated
[19]. In this paper, these four striatal binding values are used
as neuroimaging biomarkers.
C. Prediction models for distinguishing early PD and healthy
normal subjects
In this study, four different machine learning classifiers
are chosen for classification task. A brief description of
each of them is provided in this section. WEKA [20] is
used for classification using Multilayer Perceptron, Bayesian
Network, Random Forest, and Boosted Logistic Regression.
The main motive is to find an algorithm that can improve
the already reported accuracy as well as to see how various
models are performing. Firstly, the dataset is normalized using
the Normalize filter in WEKA [20].Then then the dataset
is divided in such a way that 70% is used for training
and the rest 30% is used for testing. While partitioning the
dataset the same class proportion in both the test and train
data is maintained. For example, if the proportion of healthy
people in the complete data is 40% then both in training
and testing the proportion of healthy people to PD subjects
is maintained at 40%. This type of partitioning is known as
stratified partitioning. The accuracy, recall, precision and f-
measure for each these algorithms are computed and the ROC
of each of the classifiers are plotted. Finally the performance
measure of different classifiers used in this paper as well as
in [3] are compared.
1) Multilayer Perceptron: Multilayer perceptron is a feed-
forward artificial neural network. The basic principle of mul-
tilayer perceptron is that it takes the input and maps it to
a nonlinear space, then it tries to predict the corresponding
outputs. A MLP architecture is viewed as a multiple layers
of nodes, with each layer being fully connected with the next
layer. Each node in the MLP is interpreted as a neuron that
has an activation function which is non-linear [21] [22]. The
back-propagation algorithm which is a supervised learning
technique is used for training the model. The number of
hidden layers in the MLP have a significant impact on the
TABLE I: Performance Measures for various classifiers used in the study
Performance Measures Multilayer Perceptron BayesNet Random Forest Boosted Logistic RegressionTraining Testing Training Testing Training Testing Training Testing
Accuracy(%) 96.09 95.4545 96.5854 96.027 100 96.59 95.8537 97.1591
Recall 0.961 0.955 0.966 0.960 1 0.966 0.959 0.972
Precision 0.962 0.955 0.967 0.965 1 0.970 0.959 0.974
F-Measure 0.961 0.955 0.966 0.961 1 0.967 0.959 0.972
AUC 0.989 0.986 0.994 0.994 1 0.997 0.995 0.989
performance of the classifier.
2) Bayesian Network: The Bayesian network is one of the
probabilistic graphical models used in machine learning. The
Bayes Net corresponds to graphical model structures which
are known as directed acyclic graph (DAG). This graphical
models are understood in the following manner [23]. The
nodes in the graph represent the random variables and the
edge between node x and node y denotes the probabilistic
dependencies among random variables corresponding to the
respective nodes. Hence the nodes that are not connected in
the Bayesian network are the random variables which are inde-
pendent to each other. Different computational and statistical
methods are used to estimate the conditional dependencies.
Bayes Network learning uses various search algorithms and
quality measures. In the present model K2 learning algorithm
for searching is used.
3) Random Forest: Random forest are part of ensemble
learning method that is used for classification, regression and
other tasks. In Random forest, there are many decision trees.
For a given input, each of the decision trees classify it as
yes/no (in case of binary classification)[24] [25]. Then once
each of the trees have classified as yes/no, the value which has
the majority among them is taken as output. The advantages
are that this algorithm runs effectively on large inputs and it
also helps in estimating which of the features are important.
4) Boosted Logistic Regression: Logistic regression was
developed by statistician David Cox in 1958[26] [27]. A
logistic model is used to predict the binary class using one or
more features. Logit- the natural algorithm for an odds ratio
is the central mathematical concept behind logistic regression.
Logistic regression is well suited in case when one wants to
establish relationship between a categorical outcome variable
and one or more categorical or continuous predictor variables
[28].
Boosting is a machine learning ensemble meta-algorithm
for primarily reducing bias, and also variance in supervised
learning. It belongs to the family of machine learning algo-
rithms which convert weak learners to strong ones. AdaBoost
is used for boosting different classifiers.
IV. RESULTS AND DISCUSSION
Table 1 shows the performance of various classifiers used
in the study. Fig 2 shows the corresponding ROC plots. In
Multilayer Perceptron the back propagation algorithm is used
to train the model. The learning rate is set at 0.4 and number
of hidden layers is chosen as 8 in this case ((number of
attributes + number of classes)/2 =8). In BayesNet various
search algorithms and quality measures are used. A Simple
Estimator is chosen for estimating the conditional probability
tables of a Bayes network once the structure has been learned.
For searching K2 algorithm is used. It uses a hill climbing
algorithm which is restricted by an order on the variables. In
boosted logistic regression Adaboost M1 method is used to
boost the logistic regression.
It is observed that all the classifiers performed reasonably
well with boosted logistic regression giving the best perfor-
mance with 97.16% accuracy and 98.9% area under the ROC
(AUC). Table 2: shows how this models performed in relation
to the previous work [3]. It is found that the accuracy and
area under the ROC curve are nearly same among the different
classifiers used. The present work and [3] have the advantage
that the dataset used is very large as compared to others.
However, it is noted that the PPMI study includes subjects
who are in early stages of PD and healthy normal, however it
doesn‘t include subjects who are having premotor symptoms
but are not diagnosed as PD due to lack of motor symptoms.
V. CONCLUSION
The diagnosis of Parkinson’s Disease is not direct which
means that one particular test like blood test or ECG cannot
determine whether a person is suffering from PD or not.
Doctors go through the medical history of a patient, followed
by a thorough neurological examination. They find out at least
two cardinal symptoms among the subjects and then predict
whether the subject is suffering from PD. The misdiagnosis
rate of PD is significant due to a no definitive test. In such
case it will be helpful for us to aid the doctor by providing a
machine learning model. The prediction models are developed
using machine learning techniques of boosted logistic regres-
sion, classification trees , Bayes Net and multilayer perceptron
based on these significant features. It is observed that the
performance is better. It is demonstrated that Boosted Logistic
Regression produce superior results. These results encourage
us to try other ensemble learning techniques. The present
work employs different machine learning algorithms which
are not used in [3]. This study plays an important role in
having a comparative analysis of various machine learning
algorithms. In conclusion, this models can provide the nuclear
experts an assistance that can aid them in better and accurate
decision making and clinical diagnosis. It is also found that the
proposed method is fully automated and provides improved
performance and hence can be recommended for real life
applications.
TABLE II: Comparative Analysis of Machine Learning models
in the current work and previous work
Machine Learning Algorithms Accuracy(%) AUC(%)Training Testing Training Testing
Multilayer Perceptron 96.09 95.45 98.9 98.6
BayesNet 96.5854 96.02 99.4 99.4
Random Forest 100 96.59 100 0.997
Boosted Logistic Regression 95.8537 97.16 99.5 98.9
Boosted Trees 100 95.08 100 98.23
Naive Bayes 94.67 93.12 98.66 96.77
Support Vector Machine 97.14 96.40 99.27 98.88
Logistic Regression 96.50 95.63 99.20 98.66
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Fig. 1: Flow Chart of the proposed analysis
(a) ROC for Classification using Multilayer Perceptron (Test Data) (b) ROC for Classification using BayesNet (Test Data)
(c) 1f ROC for Classification using Random Forest (Test Data) (d) ROC for Classification using Boosted Logistic Regression(Test Data)
Fig. 2: ROC Plots for different machine learning algorithms
X-axis = False Positive Rate Y-axis = True Positive Rate
